28,482 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Bought by Natixis Advisors LLC
Natixis Advisors LLC bought a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 28,482 shares of the biopharmaceutical company’s stock, valued at approximately $857,000. Several other institutional investors also recently […]
Natixis Advisors LLC bought a new stake in shares of TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 28,482 shares of the biopharmaceutical company’s stock, valued at approximately $857,000. Several other institutional investors also recently […]
